Healthcare & Life Sciences
VedaCorp advises Suguna Group on divestment of its animal health business, Globion to Virbac
About
Suguna Group
Suguna Group was founded in 1984 and is one of India’s leading poultry conglomerates with annual turnover of ~USD 2 Bn. The group’s business interests include broiler farming, hatcheries, feed mills, processing plants and vaccines manufacturing for poultry. It markets and exports broiler chicken, frozen chicken and chicken eggs. The group has its presence in 4 countries and a network of 70+ hatcheries and feed mills and a family of 40,000+ farmers.
Globion
Globion was founded in 2005, as a joint venture between Suguna Group, one of the leading Indian poultry conglomerates, and Lohmann Animal Health, a German poultry vaccines specialist, Globion has developed robust know-how and expertise in the development, manufacturing and commercialization of live and inactivated vaccines targeting a large array of avian pathogens. The company is based in Hyderabad where its industrial and R&D facilities employ around 120 full-time employees and is independently run by a professional team.
Background
We are pleased to announce that our client, Coimbatore head quartered, ~USD 2 Bn Poultry Conglomerate, Suguna Group, has signed definitive agreements to divest 100% of Globion India Pvt Ltd (Globion) to Virbac Group, a EUR 2+Bn Euronext-Paris listed multinational animal health company. Headquartered in France Virbac is the 6th largest Animal Health Company in the world. This marks Virbac’s lagrest acquisition in India.
Globion was founded in 2005, as a joint venture between Suguna Group, and Lohmann Animal Health, a German poultry vaccines specialist. It is an independently run professional organisation based in Hyderabad and is one the fastest growing poultry vaccines player in India and sells across the country and few export markets as well.
Veda Corporate Advisors (“VedaCorp”) was the exclusive financial advisor to Suguna Group and Globion on this transaction. VedaCorp provided comprehensive transaction advisory services covering identification of prospective investors, strategic positioning, and negotiation of key commercial terms.
VedaCorp was successful in generating significant interest from multiple global and domestic Animal Health companies through a competitive time-bound bid process resulting in the successful outcome of the transaction harnessing our global network of investment banks, Infinita alliance.
This is VedaCorp’s 51st transaction in the healthcare & life sciences space and 10th transaction in the last 1 year.